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 Macromolecular crystallography allows for the determination of structures to 
an atomic resolution and can provide important insight into the function and 
mechanism of enzymes. Including enzymes involved in interesting reactions and 
complex formations. In Wolinella succinogenes a sulfur carrier protein pathway was 
discovered to serve as the sulfur source for methionine biosynthesis. During this 
process, the sulfur carrier protein HcyS must form complexes with a variety of 
proteins to accomplish the C-terminal thiocarboxylate formation and the biosynthesis 
of methionine. This ability to form the different complex interactions makes the 
pathway fascinating in its structural characteristics. Additionally, the methionine 
pathway has a novel sulfur source when compared to other sulfur carrier protein 
pathways. The sulfur for the thiocarboxylate is supplied by ferredoxin sulfite reductase 
(FSR). The structure of FSR has been solved and reveals a more complex function 
than simply reducing sulfite to sulfide. The presence of a cysteine in the active site 
suggests the FSR may also serve as a sulfurtransferase to control the formation of the 
sulfur carrier protein thiocarboxylate. The structure of FSR provides further insight 
into the formation of complexes by HcyS.     
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CHAPTER 1: INTRODUCTION 
Structural biology is a field tasked to discover and understand the structural basis of 
molecular processes, and is based on the idea that to understand it is necessary to see. Several 
tools are available to gain this structural information including electron microscopy, nuclear 
magnetic resonance (NMR), small angle X-ray scattering (SAXS), and X-ray crystallography [1, 
2]. Electron microscopy can provide low resolution structural information about interactions of 
macromolecules, while NMR presents dynamic structures for aqueous solutions. Small angle X-
ray scattering provides a view of the molecular envelope. X-ray crystallography is among the 
most powerful of these techniques, as it can offer higher resolution information of a static 
structure within a crystal lattice [1]. 
Cryo-electron microscopy (cryo-EM) is a technique that uses a beam of electrons focused 
by electrical fields to see a magnified image of very large proteins and complexes [3]. This 
method produces a low resolution structural image of the macromolecule, up to approximately 4 
Å though more often in the 10-25 Å range. It can give a snapshot of a dynamic conformational 
landscape. In cases of high resolution cryo-EM (4 Å), it is possible to build a model into the 
image, though this is usually limited to proteins with high symmetry and rigid structures, such as 
virus particles (Figure 1.1) [4, 5]. Staining by metals to more strongly scatter the electron beam 
is common in other types of EM but the staining method produces distortions in the structure that 
are not acceptable for high resolution structures. For this reason, cryo-EM samples are not 
stained and are instead flash-frozen with a cryo-protectant similar to the method used in X-ray 
crystallography that will be discussed later in this chapter. To obtain higher resolution images, it 
also makes use of image enhancement, which combines the Fourier transform with electron 
imaging to increase resolution and decrease the signal to noise  
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Figure 1.1. (a) Cryo-EM image modified from [4] that shows the cryo-EM image of a 
rotavirus particle. (b) Cryo-EM of one of proteins that make up the virus particle   
 
ratio making it easier to resolve the image. The use of the Fourier transform, however, averages 
the images of all the particles yielding a single image that represents the conformation to all 
particles in the solution. This can be problematic if the solution is heterogeneous, which 
compromises the averaged image [5]. The method is limited because of the resolution, and 
provides snapshots of macromolecules of greater than 70 kDa, but image sorting can provide 
information about conformational changes. All together, these images can provide a more 
complete picture of dynamic formations, and can provide structural information that can be used 
to infer function [6]. 
A high profile example of the power of cyro-EM is shown by studies of the kinesin motor 
protein, which drives motility [7]. This protein converts ATP energy into unidirectional motion 
along the microtubule network. They are involved in intracellular transport and control of 
microtubule dynamics and signal transduction, and are conventionally dimers of identical 120 
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kDa monomers. Cryo-EM  was used to visualize conformational changes of  a flexible linker and 
propose a mechanism for how these motions drive motility along the microtubule [7].    
NMR is used to obtain structural information for proteins in solution. It has limitation on 
the size of proteins whose structure can be determined by this method, and is often limited to 
proteins with molecular masses less than 30 kDa. The larger the protein, the more peaks in the 
NMR spectrum, generally creating an upper limit for structure determination by NMR of 
approximately 50 kDa [8]. Because of the peak overlap, 2D and 3D spectrum techniques are 
used, but overlap of peaks still occurs for larger proteins (Figure 1.2).  
The basic NMR experiment involves placing the sample between the poles of two 
powerful magnets creating nuclear spin, and a radio frequency pulse is transmitted to the sample. 
The sample absorbs this energy then relaxes releasing a radio frequency signal to the detector 
that contains the chemical shift information of the nuclei. This is 1D NMR, which only gives 
chemical shift information. 2D NMR gives information not only about the chemical shift, but 
also about coupling between the nuclei of adjacent atoms. This experiment involves a complex 
series of pulses, delays, and data collection. But it is necessary for larger molecules such as 
proteins in order to separate the complex shifts that will allow for model building [3].  
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Figure 1.2. Comparison of NMR 1D (top) and 2D (bottom) for the same protein  
With 2D NMR, the peaks of the NMR spectrum can provide information on the 
environment of a residue, and then by looking at this environment the peak can be associated 
with a specific residue. Once all the peaks are assigned to specific residues, the information can 
be compiled to build a structural model of the protein [8]. Once the structure is determined, 
further experimentation can be done with NMR including the addition of ligands, or even other 
proteins to form a complex. The addition of these molecules can provide a real-time dynamic 
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representation of the conformational changes that take place when the protein binds a ligand or 
another protein [9]. NMR solution structure has been applied to many proteins. One high profile 
example, that is not amenable to X-ray crystallography, is the structure of human prion proteins, 
which are associated with fatal disease characterized by loss of motor control, dementia, and 
paralysis [10]. Solution of these structures is very important because of the serious nature of the 
diseases in which they are involved and can lead to treatment options. NMR was used to solve 
the structures of human versions of the prion proteins to identify conformational changes that 
lead to the aggregation of the protein during the onset of the disease (Figure 1.3) [10]. 
 
 
Figure 1.3. Model of NMR solution structure of the human prion protein. Figure adapted 
from [10] 
  
SAXS is a technique used for structural characterization of non-crystalline materials 
including macromolecular proteins [11]. A chaotically dispersed protein solution is irradiated 
with an X-ray beam, and the scattered X-rays are recorded. A scattering profile of a 
macromolecule can give information about the molecular mass, and consequently the oligomeric 
state or stochiometry of complex formation. Differences in this scattering profile can also 
indicate if the protein is unfolded or disordered [12]. First, the solvent scattering is recorded by 
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using a blank that contains only buffer, then the scattering data is collected for the sample 
containing the molecule of interest. The solvent scattering is then subtracted from the sample 
scattering to create a scattering curve for the macromolecule (Figure 1.4) [13]. 
Δρ(r)=ρ(r)-ρ(s) 
Figure 1.4. Equation of the SAXS scattering: the scattering of the solvent (ρ(s)) is subtracted 
from the scattering of the solution to determine the scattering of the molecule of interest. 
 
The resulting scattering curve I(q) is radially symmetric (isotrophic) due to the randomly 
oriented molecules in the solution, and is a function of the magnitude of the scattering vector 
(Figure 1.5). The scattering curve of a homogenous solution can then be derived from the 
electron distribution of the particle P(r) shown in Figure 1.6. The equation used to create the 
scattering curve is shown in Figure 1.7.  
Figure 1.5. Scattering vector equation where 2θ is the scattering angle and λ is the 
wavelength of incident X-ray beam. 
 
Figure 1.6. Electron distribution of the particle, pair-wise distribution function 
 
Figure 1.7. Scattering curve equation where P(r) is the electron distribution particle and 
Dmax is the maximum distance in the scattering particle  
 
 The scattering curve can then be analyzed at different values to extract different 
parameters about the molecule. At lower q values this includes the radius of gyration (Rg), which 
gives an estimation of molecular size, and the intensity at the zero angle (I0), which is necessary 
for molecular mass calculation. Higher q values hold information about the molecular shape, and 
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can be particular important for characterization of folded versus unfolded protein, and flexibility 
of folded proteins with linker regions. 
One example of the usefulness of SAXS in structural studies is in exploring the 
dimerization of a blue-light signal transduction protein, Vivid (VVD) [14]. VVD is dependent on 
light for signal transduction. Photon absorption causes a conformational change in a domain of 
VVD and this conformational change leads to a monomer-dimer equilibrium. SAXS was used to 
determine the dimerization of the VVD, after the excitation of the sample with a laser the I(0) 
increased suggesting a higher molecular weight indicative of dimer formation [14].   
 X-ray crystallography is the most powerful and most commonly used method for 
obtaining structural data [3]. The power of X-ray crystallography is based on the idea that 
function is determined by structure, and that accurate, atomic resolution structural data can 
provide much information about a protein's function. The atomic details of structures can help 
elucidate the mechanism of an enzyme, which residues are involved in binding the substrate, and 
which residues participate in catalysis. X-ray crystallography has supplied a great deal of 
information for mechanistic enzymology by providing structures of protein complexes with 
substrates, products, intermediates, or their analogs. Protein complexes can often be co-
crystallized and provide information about the residues important for complex formation, and 
how proteins of the complex contribute to the mechanism of action. It is often possible to trap a 
ligand in the crystal structure through the use of co-crystallization or soaking techniques. This 
allows for the identification of key catalytic residues, and a proposal of mechanism, which can 
suggest further experiments to provide evidence of function. It is also possible that a mutant 
enzyme will partially catalyze the substrate trapping an intermediate in the crystal structure. This 
can provide further information for mechanistic proposals. 
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The enzymes mechanism and ligand binding profile can then be used for structure guided 
drug design often to design a molecule that will tightly bind in the enzyme's active site and 
inhibit its function [15]. The role of protein drug target crystallography is increasing as the 
number of therapeutic drugs on the market that were directly designed using crystallography 
increases. Among these is the human immunodeficiency virus (HIV) protease inhibitor that was 
designed using the HIV protease structure [16]. Structure guided drug design can also be seen in 
the 2012 Nobel Prize in Chemistry, which was awarded to Robert J. Lefkowitz and Brian K. 
Kobilka for their work on the crystal structure of G-protein coupled receptors (GPCRs) (Figure 
1.8). GPCRs are membrane proteins that mediate signals from the outside of the cell, and are of 
interest as pharmacological targets to treat a variety of conditions. This work has allowed for the 
design of small molecule inhibitors and agonists that increase or decrease the signaling activity 
as necessary for the physiological condition being treated [17].  
 
 
 
Figure 1.8. GPCRs structures superimposed to show the conservation of the structure. 
Figure adapted from [18] 
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 Advances in technology have increased the ease of structure determination, and has 
expanded the use of X-ray crystallography to nonspecialists. Structure determination by X-ray 
crystallography is relatively straightforward as illustrated in Figure 1.9. However, practical 
challenges, such as growing protein crystals and obtaining accurate phases can be problematic. 
Figure 1.9. Flowchart of the protein crystallography experiment 
Preparing and modifying a sample to allow for crystallization can be nontrivial, and often 
involves careful planning and understanding of the target protein [19]. Crystals must be very 
well ordered, containing many copies of the protein in identical orientations, to create high 
resolution X-ray diffraction patterns. Optimizing the crystallization condition to increase the 
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quality of the crystals can be a difficult process, and in some cases crystal quality will prevent 
structure determination. In this case, it becomes necessary to start the process again to find a new 
crystallization condition [3].  
 Once the crystals are grown, the crystals must be flash frozen in liquid nitrogen to 
decrease the radiation damage to the crystal during data collection. When freezing the crystals, 
the crystallization condition must be supplemented with cryo-protectant to prevent ice formation, 
which will disrupt the arrangement of molecules in the crystal. Typical cryo-protectants include 
glycerol and ethylene glycol ranging from 10-30% (Figure 1.10). 
       
Figure 1.10. Example picture of a crystal in a loop for  data collection 
 
  
An X-ray diffraction experiment is performed by placing a single crystal in a focused X-
ray beam and recording diffraction images. Because X-rays cannot be focused by lenses it is not 
possible to view an image of a molecule through this method, as is done in optical microscopy 
[3]. Instead, the electron density of the molecules in the crystal diffracts the X-ray beam to create 
a diffraction pattern (Figure 1.11).  Each diffraction maximum is characterized by a set of Miller 
indices (h, k, l) and a diffraction angle known as 2θ or the Bragg angle.  The value of this angle 
is determined by the wavelength of the X-rays, the unit cell parameters (a, b, c, , , ), and the 
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orientation of the crystal. 
 
Figure 1.11. Example image of a diffraction pattern 
 The intensity of each maximum is the square of the structure factor F, which is calculated using 
the equation shown in Figure 1.12.  
 
Figure 1.12. F(h, k, l) is the structure factor, h, k, l are the Miller indices of the structure 
factor, fj is the resolution-dependent atomic scattering factor, (x, y, z) are the fractional 
positions of the atom j in the unit cell.  
 
The structure factor intensities of the diffraction image and the phases are combined to 
reconstruct the electron density by a Fourier transform (Figure 1.13).  
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Figure 1.13. Fourier transform equation that is used to convert diffraction data to an electron 
density map 
 
 
 
Figure 1.14. The 24-ID-C hutch used for X-ray crystallography data collection at the 
Northeastern Collaborative Access Team (NE-CAT) beamline at the Advance Photon 
Source (APS) in Argonne National Labs, Argonne, IL 
 
Data collection usually takes place at a synchrotron beamline configured for macromolecular 
crystallography (Figure 1.14). Once the data collection is complete, phase information must be 
generated for calculation of electron density maps. The diffraction images collected for a crystal 
contains only intensities of the diffractions spots, but not the phase of the diffracted X-ray wave. 
Several methods can be used to obtain phases, including molecular replacement, 
multiwavelength anomalous diffraction (MAD), single-wavelength anomalous diffraction 
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(SAD), and direct methods. In molecular replacement, the phases from structure factors of a 
known protein structure are used to determine the initial phases by placing the phasing model 
into the unit cell of the new protein [3]. The molecule used for phasing is identified by sequence 
alignments to find proteins that are predicted to be structurally similar to the protein of interest. 
If this method can be used, then the structure can be determined from a single native data set.  
MAD and SAD phasing uses incorporation of a heavy atom to perturb the X-ray 
diffraction pattern of the protein crystal. The heavy atom is often selenium, which can be 
incorporated by replacing methionine residues with selenomethionine, or by soaking crystals in 
solution containing metals, which can bind to the protein surface. In MAD phasing at least two 
data sets are collected from the same crystal but at different wavelengths, one of which is the 
wavelength of maximum absorbance for the heavy atom and the other is shifted away from this 
maximum value.  The differences in the diffraction intensities for the two wavelengths can be 
used to obtain the phases [3]. SAD phasing is very similar except that it requires only one data 
set at the collected at the wavelength of maximum absorption for the heavy atom. SAD is 
presently the most commonly used technique [19].  
 Practical application of direct methods is limited to structure determination for molecules 
with fewer than 200 atoms. It relies upon the conditional probabilities between the normalized 
structure factor magnitudes and the phases. While these direct methods fail for large protein 
molecules, they are used extensively for determining the location of the heavy atoms required for 
SAD or MAD phasing.  
The model is then built into the electron density map with many iterations of model 
building and refinement. The quality of the model agreement with the experimental electron 
density data can then be evaluated be the use of the Rfactor (Figure 1.15). Another useful figure 
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during refinement is Rfree which can detect overfitting by calculating the Rfactor for the current 
model using a set of reflections that are withheld from the refinement.  
 
Figure 1.15. Rfactor equation where F0 is the experimental amplitudes and Fc are the 
amplitudes calculated from the model.  
 
 In X-ray crystallography, the crystal lattice, which limits the freedom of motion, may 
affect the protein structure [19]. This usually not a serious problem because protein crystals are 
actually a two-phase system: a crystalline solid and together with aqueous solvent channels that 
provide a solution-like environment.  Comparison to solution NMR structures show similar core 
structure [20]. In cases where proteins go through large conformational changes, crystallization 
selects one conformational state. However, different crystal forms can often select different 
conformations, which allows one to infer information about protein motions and the functional 
role of conformational changes.  
 X-ray crystallography is complementary to both a variety of other experimental 
approaches and to other structural methods. The combination of X-ray crystallography with 
NMR can provide more information about how proteins move through conformational changes 
giving dynamic information to the static crystal structure [9]. It can also be combined with 
electron microscopy since such large proteins and complexes can be difficult to crystallize as a 
whole. Smaller domains of the large protein can be solved by X-ray crystallography then fitted 
into the electron microscopy image of the large complex to understand how the smaller parts fit 
together to make the larger structure [6].  SAXS can be used to characterize the oligomeric states 
and folding of the protein under different conditions that could be useful to attempts to 
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crystallize the protein [11]. Additionally, experiments such as mutagenesis, kinetics, circular 
dichroism, size exclusion chromatography and other techniques can be used to gain more insight 
into the structural information and to provide a complete story of enzyme function.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
REFERENCES 
 
 
1. Liljas, A., On the complementarity of methods in structural biology. Acta Crystallogr D 
Biol Crystallogr, 2006. 62(Pt 8): p. 941-5. 
2. Campbell, I.D., Timeline: The march of structural biology. Nature Reviews Molecular 
Cell Biology, 2002. 3(5): p. 377-381. 
3. Rhodes, G., Crystallography Made Crystal Clear: A Guide for Users of Macromolecular 
Models. 2010: Elsevier Science. 
4. Zhang, X., et al., Near-atomic resolution using electron cryomicroscopy and single-
particle reconstruction. Proc Natl Acad Sci U S A, 2008. 105(6): p. 1867-72. 
5. Spahn, C.M. and P.A. Penczek, Exploring conformational modes of macromolecular 
assemblies by multiparticle cryo-EM. Curr Opin Struct Biol, 2009. 19(5): p. 623-31. 
6. Lander, G.C., H.R. Saibil, and E. Nogales, Go hybrid: EM, crystallography, and beyond. 
Curr Opin Struct Biol, 2012. 22(5): p. 627-35. 
7. Rice, S., et al., A structural change in the kinesin motor protein that drives motility. 
Nature, 1999. 402(6763): p. 778-84. 
8. Wuthrich, K., Protein structure determination in solution by NMR spectroscopy. J Biol 
Chem, 1990. 265(36): p. 22059-62. 
9. Wuthrich, K., Six years of protein structure determination by NMR spectroscopy: what 
have we learned? Ciba Found Symp, 1991. 161: p. 136-45; discussion 145-9. 
10. Zahn, R., et al., NMR solution structure of the human prion protein. Proc Natl Acad Sci U 
S A, 2000. 97(1): p. 145-50. 
11. Mertens, H.D. and D.I. Svergun, Structural characterization of proteins and complexes 
using small-angle X-ray solution scattering. J Struct Biol, 2010. 172(1): p. 128-41. 
 
 
17 
 
12. Petoukhov, M.V. and D.I. Svergun, Applications of small-angle X-ray scattering to 
biomacromolecular solutions. Int J Biochem Cell Biol, 2013. 45(2): p. 429-37. 
13. Putnam, C.D., et al., X-ray solution scattering (SAXS) combined with crystallography and 
computation: defining accurate macromolecular structures, conformations and 
assemblies in solution. Q Rev Biophys, 2007. 40(3): p. 191-285. 
14. Lamb, J.S., et al., Time-resolved dimerization of a PAS-LOV protein measured with 
photocoupled small angle X-ray scattering. J Am Chem Soc, 2008. 130(37): p. 12226-7. 
15. Blundell, T.L., H. Jhoti, and C. Abell, High-throughput crystallography for lead 
discovery in drug design. Nat Rev Drug Discov, 2002. 1(1): p. 45-54. 
16. Greer, J., et al., Application of the three-dimensional structures of protein target 
molecules in structure-based drug design. J Med Chem, 1994. 37(8): p. 1035-54. 
17. Shukla, A.K., et al., Structure of active beta-arrestin-1 bound to a G-protein-coupled 
receptor phosphopeptide. Nature, 2013. 497(7447): p. 137-41. 
18. Kruse, A.C., et al., Applications of molecular replacement to G protein-coupled 
receptors. Acta Crystallogr D Biol Crystallogr, 2013. 69(Pt 11): p. 2287-92. 
19. Rupp, B., Biomolecular Crystallography: Principles, Practice, and Application to 
Structural Biology. 1st ed. 2009, New York, NY: Garland Science. 850. 
20. Etter, M.C., NMR and X-ray Crystallography: Interfaces and Challenges : Proceedings 
of the. 1989: Polycrystal Book Service. 
 
 
 
 
 
 
18 
 
CHAPTER 2: SULFUR CARRIER PROTEINS 
 The main focus of this thesis is the incorporation of sulfur in sulfate-dependent 
biosynthesis.  In sulfate-dependent methionine biosynthesis, sulfur incorporation occurs through 
a sulfur carrier protein. Sulfur carrier proteins are small proteins (usually less than100 amino 
acid residues) characterized by a ubiquitin-like β-grasp fold, having a four-stranded β-sheet 
flanked by at least one α-helix (Figure 2.1) [1].  
 
 
Figure 2.1. Stereoview of ubiquitin showing the β-grasp fold.  The α-helices are shown in 
blue, β-strands in green, and loops in yellow  
 
The sequence identity between sulfur carrier protein homologs is generally very low.  Ordinarily, 
the only conserved feature is a diglycine motif (Gly-Gly) at or near the C-terminus (Figure 2.2) 
[1, 2]. The structural similarity to ubiquitin and the C-terminal Gly-Gly motif suggest an 
evolutionary relationship between ubiquitin with the prokaryotic sulfur carrier proteins (Figure 
2.3) [1]. In contrast to ubiquitin, sulfur carrier proteins serve as the sulfur source for a variety of 
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biosynthetic pathways, and are very important to the biosynthesis of several molecules and 
cofactors necessary for living systems (Figure 2.3).  
 
Figure 2.2. Sequence alignment of known sulfur carrier proteins, shows the low sequence 
identity of this protein type. The C-terminal Gly-Gly motif is an identifying feature that is 
conserved throughout these protein sequences.    
 
These include vitamin B1 (ThiS) [3], molybdopterin (MoaD) [4], thioquinolobactin 
(QbsE) [5], pyrimidine dithiocarboxylic acid (PdtH) [6], cysteine (CysO) [7] , 2-
thioribothymidine (TtuB) [8] (Figure 2.4). A eukaryotic sulfur carrier protein involved in the 
biosynthesis of 5-methoxycarbonylmethyl-2-thiouridine (Urm1p), which is also used in the 
covalent lysine modification of proteins, has also been characterized, suggesting that Urm1p 
might be the evolutionary link between ubiquitin and the prokaryotic sulfur carrier proteins [9].  
Another sulfur carrier protein has been identified in Wolinella succinogenes to be involved in the 
biosynthesis of methionine, which is discussed in Chapter 3 and 4 [10].  
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Figure 2.3. Sulfur carrier proteins with the products of their biochemical pathways 
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Figure 2.4. Overlay of the structures of MoaD (blue), ThiS (yellow), and Urm1 (green). 
The proteins as can be seen all have the same fold, the flexible linker shown on the 
bottom right of the image is the C-terminal containing the Gly-Gly motif.    
 
 Ubiquitin (Ub) is a small protein that is added as a covalent modifier to a target protein as 
a cellular signal. Though it is not a sulfur carrier protein, it is similar in structure and has a 
similar mechanism of action to the prokaryotic sulfur carrier proteins [1]. Ub is activated by 
adenylation of its C-terminal by the enzyme E1 similar to the activation of the sulfur carrier 
proteins. Then E1 forms a thioester with Ub C-terminal using a catalytic cysteine residue as the 
sulfur source. The thioester Ub-E1 complex interacts with the enzyme E2 and Ub is transferred 
to a catalytic cysteine of E2 forming another thioester complex. The energy of this thioester bond 
is then used to conjugate Ub to a lysine residue of its target protein. This is either done directly 
by E2 or indirectly by the complex formation with another protein, E3 [11]. This use of thioester 
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formation, instead of thiocarboxylate formation, differs from the mechanism used by the sulfur 
carrier proteins, but the activation by adenylation of the C-terminal glycine residue is the same. 
Additionally, sulfur carrier proteins are not used as covalent modifiers of other proteins, but 
serve as the sulfur source and base for product formation. Except for the protein Urm1p and the 
recently discovered TtuB, which serve a dual function as sulfur carrier proteins and covalent 
modifiers. Both of these dual function proteins transfer the sulfur of the thiocarboxylate to a 
tRNA source.  
 Urm1p identified in Saccharomyces cerevisiea is a similar protein to ubiquitin as it acts a 
covalent modifier to proteins such as Ahp1 [12] . Urm1p is activated by the E1-like enzyme 
Uba4 [13]. Before activating Urm1p, Uba4 first accepts a sulfur from a cysteine desulfurase 
(Nfs1) to form a persulfide [9]. Uba4 has a amino terminal (N-terminal) domain that adenylates 
Urm1p C-terminal, and a C-terminal rhodanese-like sulfur transferase domain that uses a 
cysteine residue to form an acyl disulfide bond with Urm1p. The disulfide bond is reduced and 
the Urm1p thiocarboxylate is released from Uba4 [12]. Once the thiocarboxylate is formed 
Urm1p can then form a conjugate to modify a target protein under conditions of oxidative stress. 
The conjugating enzyme expected to be similar to ubiquitin's E2 has not yet been identified.  
Alternatively, the Urm1p thiocarboxylate can be used to modify tRNA, making the tRNA 
modification 5-methoxy-carbonyl-methyl-2-thiouridine (mm5s2U). The Ncs2 and Ncs6 proteins 
are involved in the transfer of the sulfur from the Urm1p thiocarboxylate to the tRNA, but the 
mechanism of this process is currently unknown [9].  The method of activation and 
thiocarboxylate formation for Urm1p is more similar to the sulfur carrier protein mechanism than 
to the mechanism seen with ubiquitin.    
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 In thermophilic organisms, 2-thioribothymidine (s2T), a 2-thiolated derivative of 
ribothymidine (rT), is found at position 54 in tRNAs. This thiolation is assumed to provide 
stability for the tRNA at high temperatures. The biosynthesis of this modified tRNA is known to 
include several enzymes including the sulfur carrier proteins, TtuB. This sulfur carrier protein is 
activated by adenylation by the enzyme TtuC. Then it accepts a sulfide from a cysteine 
desulphurase (IscS or SufS) persulfide through the intermediate acyl-disulfide bond formation. 
Once reduced and released the thiocarboxylate of TtuB interacts with TtuA and some other 
unknown factors to transfer the sulfur to make s2T [8].  However, it has recently been found that 
TtuB can act similarly to ubiquitin and conjugate to other proteins as a modification. Instead of 
forming the thiocarboxylate, the adenylated TtuB can form a thioester bond with a cysteine of 
TtuC. TtuB is then conjugated to proteins involved in thiouridine biosynthesis, changing the 
amount of s2T modifications. The conjugating of TtuB is likely to be concerned with regulation 
of the sulfur transfer [14].     
 The mechanism of the sulfur carrier proteins with no known covalent modification 
function uses a similar acyl disulfide bond to a persulfide of another protein that is seen in 
Urm1p. Then the thiocarboxylate is used to supply the sulfur source for several cofactors, 
siderophores, and amino acids. This includes the vitamin B1 or thiamin pyrophosphate 
biosynthesis in Bacillus subtilis. Thiamin is an important cofactor made up of a pyrimidine 
covalently linked to a thiazole. The two moieties are synthesized separately and then coupled to 
make thiamin [15]. The sulfur carrier protein ThiS begins the biosynthesis of the thiazole moiety 
of thiamin [3]. ThiS is activated by adenylation at the C-terminal by the ATP-dependent enzyme 
ThiF [3, 16]. The thiocarboxylate is next formed by the transfer of a sulfur from the cysteine 
desulfurase, IscS persulfide [3, 17]. The thiocarboxylate is then incorporated into the thiazole 
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moiety through a reaction catalyzed by ThiG, the rearrangement of 1-deoxy-D-xylulose-5-
phosphate (DXP) and a glycine imine intermediate. The thiazole, which then contains the sulfur 
transferred from the ThiS thiocarboxylate, is then incorporated into the biosynthesis of thiamin 
[18]. 
A sulfur carrier protein is also used in the biosynthesis of another cofactor, called the 
molybdenum cofactor. Molybdopterin (MPT) is the organic metal binding portion of the 
molybdenum cofactor (Moco). The Moco is varied by modifications and found in a large number 
of proteins involved in electron transfer. The biosynthesis of this molecule in Escherichia coli is 
accomplished by a large heterotetramer complex, MPT synthase, that contains two small sulfur 
carrier protein MoaD subunits and two large MoaE subunits [19]. Before the MPT synthase 
formation, the MoaD C-terminus is activated by adenylation by MoeB. MoeB is not directly 
involved in the transfer of sulfur to form the thiocarboxylate [4]. The sulfur comes from the 
cysteine desulfurase IscS, and is transferred to the MoaD C-terminal the rhodanese-like protein 
YnjE [20, 21]. The sulfurtransferase TusA is also involved in sulfur transfer and increases the 
efficiency of MPT biosynthesis; however, it is not known if it is involved in a direct transfer or 
indirectly transfers the sulfur to another protein, which then transfers it to MoaD [22]. Two 
MoaD C-terminal thiocarboxylates are present in MPT synthase, which catalyzes the reaction 
that incorporates the dithiolene moiety into the precursor Z to make MPT [19].  
 Thioquinolobactin is a siderophore that is produced in fluorescent bacteria Psuedomonas 
fluorescens. There are two pathways for thioquinolobactin biosynthesis: the first involves 
tryptophan catabolism to hydroxykynurenine, and the second involves the thioquinolobactin 
from quinolobactin through a sulfur carrier protein mechanism. The sulfur carrier protein for this 
pathway is QbsE, it has a C-terminal Gly-Gly motif however it is blocked by a cysteine and a 
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phenylalanine residue at its C-terminal. These two residues are cleaved by a protease QbsD. The 
exposed C-terminal Gly-Gly motif is then activated by QbsC through adenylation. QbsC forms a 
persulfide at one of its cysteine residues, the sulfur source of this persulfide formation is 
unknown. It then transfers a sulfur from the persulfide through the acyl-disulfide intermediate to 
make the thiocarboxylate, before releasing the QbsE thiocarboxylate after reduction of the 
disulfide bond. Quinolobactin acyl adenylate is then modified by the QbsE thiocarboxylate to 
form thioquinolobactin [5]. Another sulfur carrier protein PdtH from Pseudomonas stutzeri has 
been identified by an assay for sulfur carrier proteins [6]. PdtH is thought to be involved in the 
biosynthesis of a siderophore, pyridine dithiocarboxylate, but has not been characterized.  
 Finally, the biosynthesis of sulfur containing amino acids also utilizes the sulfur carrier 
proteins as a sulfur source. Cysteine biosynthesis in Mycobacterium tuberculosis can be 
accomplished using a sulfur carrier protein CysO as a sulfur source [7]. The protein MoeZ 
activates CysO by adenylation and transfers the sulfur to the CysO thiocarboxylate. MoeZ has a 
rhodanese-like domain that forms a persulfide at a cysteine residue. The source of the sulfur for 
persulfide formation is unknown [23]. CysO thiocarboxylate is added to a O-phosphoserine to 
form a thioester adduct in a reaction mediated by cysteine synthase (CysM), a β-elimination 
sulfhydrylase [24, 25]. After an nitrogen-sulfur acyl shift the CysO-cysteine is complete and the 
cysteine must only be cleaved from the CysO C-terminal by the protease Mec+ [7].   
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CHAPTER 3: THIOCARBOXYLATE-DEPENDENT METHIONINE BIOSYNTHESIS 
Section 3.1. Methionine Biosynthesis 
 The process of sulfur based amino acid biosynthesis is well understood in 
microorganisms. This is due to the importance of cysteine and methionine to a variety of cellular 
processes including protein synthesis, sulfur transfer, and methylation. The significance of these 
processes has lead to the characterization of the methionine and cysteine biosynthetic pathways. 
Methionine is one of two sulfur containing amino acids found in naturally occurring proteins, 
and is encoded by the start codon (AUG) which begins peptide synthesis. This makes it 
necessary for the biosynthesis of all proteins by the ribosome, hence methionine levels are 
necessary in abundance allowing proteins to be available for their respective functions. 
Methionine is also a precursor to an important molecule, S-adenosylmethionine (AdoMet), which 
serves as a methyl donor for a myriad of biochemical processes. In addition to serving as a 
methyl donor, AdoMet is a cofactor to the radical SAM enzymes, in which an electron is 
transferred from an iron-sulfur cluster to SAM to cleave it into methionine and the radical 5′-
deoxyadenosine. A hydrogen is then abstracted from the substrate creating a substrate radical [1]. 
In mammals, the degradation of methionine is used in cysteine biosynthesis. Interestingly, in 
bacteria the reverse takes place as cysteine can be used as the sulfur source for methionine 
biosynthesis. Because of the importance of methionine in these functions, the pathways 
responsible for its biosynthesis are well studied and understood. 
Two characterized pathways for methionine biosynthesis are known in prokaryotes 
(Figure 3.1). The first is the direct sulfhydrylation, which involves the addition of sulfur to O-
acetylhomoserine 2 to form homocysteine 3. In this pathway, homoserine 1 is modified by the 
addition of an R group (either acetyl or succinyl group) by a homoserine transferase. The acetyl 
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or succinyl homoserine 2 is then modified by the addition of sulfur by the enzyme O-
acetylhomoserine sulfhydrylase to form homocysteine 3. The second pathway is called the 
transsulfuration pathway and involves the addition of the amino acid cysteine 5 as the sulfur 
source to O-acetylhomoserine 2. This pathway begins when homoserine 1 is modified by the 
addition of a succinyl group by a homoserine transferase. Then cysteine 5 then reacts with O-
succinylhomoserine 2 to form cystathionine 6; this reaction is mediated by cystathionine-γ 
synthase. Then cystathionine 6 is cleaved by the enzyme cystathionine-β lyase to yield 
homocysteine 3 [2]. Both pathways form homocysteine 3, and finish with the final step of 
methylation of the homocysteine 3 by methionine synthase to form methionine 4. Depending on 
the species one of these pathways is usually favored over the other [3].  
 
Figure 3.1. Direct sulfhydrylation pathway (Top) and the transulfuration methionine 
biosynthesis (Bottom). 
 
Section 3.2. Thiocarboxylate-Dependent Methionine Biosynthesis 
In Wolinella succinogenes the cystathionine transsulfuration pathway is absent. Instead of 
this transsulfuration pathway, W. succinogenes biosynthesizes methionine using both the direct 
sulhydrylation pathway and a novel pathway that depends on thiocarboxylate formation of a 
sulfur carrier protein as its sulfur source [4].  
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 The thiocarboxylate-dependent methionine biosynthesis pathway was discovered in W. 
succingenes in an attempt to identify orthologs of ThiS in the SEED database 
(http://theseed.uchicago.edu/FIG/index.cgi). Despite low sequence identity between the ThiS and 
the sulfur carrier protein of this pathway (HcyS), both have the glycine-glycine C-terminal motif, 
characteristic of sulfur carrier proteins. However, in HcyS an alanine residue follows the Gly-Gly 
motif and must be removed to allow sulfur carrier protein activation. Examination of the gene 
cluster that contains this putative sulfur carrier protein showed genes for sulfur assimilation and 
methionine biosynthesis (Figure 3.2) (Table 3.1).   
 
 
Figure 3.2. The gene cluster containing the sulfur carrier protein (HcyS) and proteins for 
sulfur carrier protein activation (blue), sulfur assimilation (red), and methionine 
biosynthesis (black).  
 
Table 3.1. Functions of the proteins found in the sulfur carrier protein gene cluster.  
 
Activation of Sulfur Carrier Protein 
HcyD Metalloprotease that removes C-terminal alanine of HcyS. Also 
cleaves the homocysteine from the HcyS-Homocysteine adduct.  
HcyF ATP utilizing enzyme that adenylates  HcyS C-terminal 
HcyS Sulfur Carrier Protein 
Sulfur Assimilation 
CysD/CysN Sulfate adenylyltransferase subunits 1 and 2 
CysH Phosphoadenylyl-sulfate reductase/ Adenylyl-sulfate reductase 
FSR Ferredoxin sulfite reductase reduces sulfite to sulfide and is 
involved in the transfer of sulfide to the HcyS thiocarboxylate 
1011 Hypothetical protein probably involved in sulfate reduction 
Methionine Biosynthesis 
MetY O-acetylhomoserine sulfydrylase 
MetE Methyltransferase 
MetZ O-acetylhomoserine or O-succinylhomoserine sulfhydrylase 
1014 Putative efflux protein 
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 Methionine biosynthesis starts with the absorption of sulfate 7 from the environment. The 
sulfate 7 is adenylated by ATP sulfurylase to make adenosine 5′-phosphosulfate (APS, 8) (Figure 
3.3a). APS 8 is then phosphorylated in the 5ʹ position by APS kinase to form 3'-
Phosphoadenosine-5'-phosphosulfate (PAPS, 9). Then PAPS reductase forms sulfite 10 from 
PAPS 9. The PAPS reductase performs this two electron transfer through the use of the cofactor 
thioredoxin or glutaredoxin as an electon source. This part of the pathway is a common part of 
the bacterial sulfur utilization pathway (Figure 3.3a) [5]. The sulfur carrier protein pathway 
(Figure 3.3b) begins with the sulfur carrier protein HcyS, which has the C-terminal Gly-Gly 
motif and an extra C-terminal alanine residue. The first step is to remove this Ala to expose the 
Gly-Gly, this is accomplished by the metalloprotease HcyD, in which the two proteins form a 
complex and HcyD removes the Ala.  The purpose of this step is unknown, but could serve a 
regulatory role. For example, if cleavage of alanine is the rate-limiting step of the pathway, it 
could provide some level of cellular control for product formation. After the Gly-Gly motif is 
exposed, HcyF, an ATP utilizing enzyme, adenlyates the C-terminal of HcyS to activate it for 
thiocarboxylate formation. The sulfite 10 supplied from sulfate reduction is then reduced by 
ferredoxin sulfite reductase (FSR), which is a large multiple domain protein with a sulfite 
reductase region and sulfurtransferase region. The sulfide is transferred to HcyS by a 
nucleophilic attack to form the protein thiocarboxylate. The thiocarboxylate is then used in 
methionine biosynthesis. MetY catalyzes the pyridoxal 5ʹ-phophate (PLP) dependent 
condensation of the HcyS thiocarboxylate and O-acetylhomoserine (OAH, 11) to form a 
transient thioester adduct 12. An S,N-acyl shift quickly occurs to form HcyS-homocysteine  13. 
Then the homocysteine 3 is cleaved from HcyS by HcyD. The homocysteine 3 is then 
methylated by MetE using methyltetrahydrofolate as the cofactor to make methionine 4 (Figure 
3.3b). 
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Fig 3.3. (a) Pathway for sulfate reduction to sulfite (b) Thiocarboxylate-dependent 
methionine biosynthesis using the sulfite incorporated from the sulfate reduction. 
 
In the thiocarboxylate-dependent methionine biosynthesis pathway only two protein 
structures have been determined: FSR, which is discussed in Chapter 5, and MetY. MetY is an O-
acetylhomoserine sulfhydrylase (OAHS) which uses the cofactor PLP to catalyze the 
condensation of HcyS thiocarboxylate to (OAH). The structure of MetY reveals a 
homotetrameric structure (Figure 3.4). Comparision of the MetY to other enzyme structures 
revealed that it has the same fold as a Saccharomyces cerevisiae cystathionine γ-lyase (PDB code 
1N8P) [6] and a Pseudomonas putida methionine γ-lyase (PDB entry 2O7C) [7]. This 
information along with active site similarity suggest that MetY is in the Cys/Met metabolism 
PLP-dependent enzyme family. The Cys/Met family is responsible for a variety of reactions 
(a) 
(b) 
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including γ-replacements, γ-eliminations, and β-eliminations [7]. Published biochemical data [4] 
along with this structure lead to the identification of MetY as a γ-elimination enzyme. This is 
also the same enzyme  type as CysM, which catalyzes the transfer of the sulfur from the CysO 
thiocarboxylate to O-phophoserine in the sulfur carrier protein-dependent cysteine biosynthesis 
pathway discussed in Chapter 2 [8]. The structure comparison also helped to identify the active 
site where PLP was modeled in using water binding in the crystal structure active site to identify 
key residues important for binding. The adjacent monomers that make up the tetramer have two 
active sites that face away from the tetramer interface.  Each of the monomers contains a putative 
PLP binding site, though PLP was not present in the crystal structure. The active site is a large 
cavity that is open to solvent. 
 
 
 
 
Figure 3.4. The homotetramer structure of MetY with PLP modeled into the active site as 
spheres (adapted from [9]). 
 
 The active site of the MetY is solvent accessible suggesting that the C-terminal of HcyS 
would have space to interact with the active site. The structure of HcyS and MetY in complex 
has not been solved so the protein-protein interactions that lead to this PLP-dependent 
condensation reaction are unknown. The proposed mechanism of the condensation reaction is 
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shown in Fig 3.5. The mechanism begins with the MetY residue Lys205 covalently bound to PLP 
14. A transimination between 14 and OAH 11 forms imine 15. Then a deprotonation occurs to 
yield 16. A second deprotonation occurs to form the stabilized carbanion 17. The acetyl group is 
then eliminated from 17 to make 18. These steps are reversed as shown in molecules 19 and 20 
to form molecule 21. The product is released through a transimination reaction to reform 14 and 
the transient HcyS-homocysteine thioester 12. Then a spontaneous S,N acyl shift occurs to form 
a fused HcyS-homocysteine 13 [8]. 
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Figure 3.5. Proposed mechanism for MetY catalyzed PLP condensation (adapted from 
[9]). 
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CHAPTER 4: STUDIES OF COMPLEX FORMATION OF THE SULFUR CARRIER 
PROTEIN HCYS 
Section 4.1. Introduction 
The sulfur carrier protein HcyS plays a key role in the biosynthesis of methionine is the 
ε-proteobacteria Wolinella succinogenes. Similar to other identified sulfur carrier proteins 
involved in biosynthesis pathways. HcyS was identified as a sulfur carrier protein when 
searching for ThiS homologs, and found to be clustered with genes involved in methionine 
biosynthesis. Like other sulfur carrier proteins, in the course of the creation of the 
thiocarboxylate and the biosynthesis of methionine, HcyS must interact with a variety of other 
enzymes.  
First the C-terminal alanine residue must be removed by the metalloprotease HcyD to 
expose the Gly-Gly motif. Then HcyS must interact with the activation enzyme HcyF to 
adenylate the C-terminal. Next, the thiocarboxylate is formed by the interaction with FSR. The 
HcyS thiocarboxylate then undergoes a PLP-dependent condensation reaction by interaction with 
MetY to form the HcyS-homcysteine. Finally, the homocysteine is removed from the HcyS C-
terminal by another interaction with HcyD [1]. The structural properties that allow this protein to 
form such a variety of interactions and complexes are not well understood and are structurally of 
interest. 
Section 4.2. Materials and Methods 
Cloning and Overexpression HcyS, HcyF, and HcyD 
 HcyS, HcyF, and HcyD genes were cloned into the pET-28-based vector (Novagen) with 
a N-terminal six-histidine tag using standard molecular biology techniques [2,3]. HcyS, HcyF, 
and HcyD were expressed in E. coli B834(DE3) cells. Overnight cultures were grown by 
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transferring a single colony into 30 mL of LB media supplement with 30 µL of 40 mg/mL 
kanamycin. LB media (1L) was inoculated with 10 mL of the overnight cultures. The cells were 
grown at 37 °C to an OD600 of 0.4. The cultures were then chilled to 15 °C and when the OD600 
reaches 0.6, isopropylthio-β-D-thiogalactopyranoside (IPTG) was added to a final concentration 
of 1 mM. Shaking was continued for approximately 16 hours at 15 °C. Cells were pelleted by 
centrifugation at 4 °C for 30 minutes at 3300g. Cell pellets were stored at -20 °C until 
purification 
Purification of HcyS, HcyD, HcyF 
Cells were resuspended in 30 mL of buffer A [20 mM 2-amino-2-hydroxylmethyl-
propane-1,3-diol (Tris) (pH 8.0), 333 mM sodium chloride (NaCl), and 10 mM imidazole]. Cells 
were lysed by sonication, and cell lysate was separated by centrifugation at 4 °C for 45 minutes 
at 48000g. Proteins were purified by nickel affinity chromatography; the clarified lysate was run 
over 3 mL of nickel resin pre-equilibrated with buffer A at a flow rate of 1 mL/min. The column 
was washed with ~20 column volumes of buffer A. The protein was eluted with three column 
volumes of buffer A supplemented with 250 mM imidazole. The eluted protein was further 
purified by size-exclusion chromatography on an ÄKTAexplorer FPLC with a HiLoad 26/60 
Superdex prep-grade G200 column in buffer B [20 mM Tris (pH 8.0), 50 mM NaCl]. After the 
chromatography step the protein purity was determined by SDS-PAGE.  
Cloning and Overexpression of HcyS-Intein 
  HcyS (without the C-terminal alanine) was inserted between the NdeI/SapI restriction 
sites in pTYB1, an intein encoding plasmid [1,2]. Overnight cultures were grown by transferring 
a single colony into 30 mL of LB media supplement with 30 µL of 100 mg/mL ampicillin. LB 
media (1L) was inoculated with 10 mL of the overnight cultures. The cells were grown in LB 
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(1L) media at 37 °C to an OD600 of 0.4. The cultures were chilled to 15 °C until the OD600 
reaches 0.6 then the cultures were put on ice for two hours. Then IPTG was added to a final 
concentration of 0.4 mM. Cells were pelleted by centrifugation at 4 °C for 30 minutes at 3300 g. 
Cell pellets were stored at -20 °C until purification.  
Purification of HcyS-Intein 
Cells were resuspended in 30 mL of column buffer [20 mM Tris (pH 8.5), 500 mM 
NaCl]. Cells were lysed by sonication and the cell lysate was separated by centrifugation at 4 °C 
for 45 minutes at 48000 g. The HcyS-intein fusion protein was purified by chitin affinity 
chromatography. A column of approximately 20 mL of chitin resin was pre-equilibrated with ten 
column volumes of the column buffer. The clarified cell lysate was run over the pre-equilibrated 
column at a rate of 0.5 mL/min. The column was washed with approximately ten column 
volumes of the column buffer. The chitin resin was then quickly washed with three column 
volumes of the cleavage buffer [20 mM Tris (pH 8.5), 500 mM NaCl, 50 mM dithiothreitol 
(DTT)]. The column was then incubated in 10 mL of the cleavage buffer for 40 hours at 18 °C. 
The HcyS protein (without alanine) was then eluted with five column volumes of the column 
buffer. The eluted protein was further purified by size-exclusion chromatography on an 
ÄKTAexplorer FPLC with a HiLoad 26/60 Superdex prep-grade G75 column in buffer B [20 
mM Tris (pH 8.0), 50 mM NaCl]. After the chromatography step the protein purity was 
determined by SDS-PAGE.  
HcyS complex formation 
 The proteins HcyS and HcyD were purified as stated above and the elutant from the 
nickel column purification were mixed. The proteins were incubated together for three hours. 
The mixed proteins were then purified by size exclusion chromatography on an ÄKTAexplorer 
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FPLC with a HiLoad 26/60 Superdex prep-grade G75 column in buffer B [20 mM Tris (pH 8.0), 
50 mM NaCl]. The peaks of the size exclusion chromatography trace were then tested for 
complex formation by SDS-PAGE. This procedure was repeated with the purified HcyS and 
HcyF, and HcyS and FSR. The HcyS/HcyD complex peak was concentrated to 15.0 mg/mL from 
the Bradford assay [4]. There was no peak for the HcyS/HcyF or the HcyS/FSR complex 
proteins concentrated separately to 13.0 mg/mL for HcyS, 14.0 mg/mL HcyF and 13.0 mg/mL 
for FSR from the Bradford assay [4]. All samples were flash frozen and stored at -80 °C.    
Crystallization of the HcyS/HcyD complex 
 Frozen protein samples were thawed at 24 °C and crystallization was carried out by 
hanging-drop vapor-diffusion method at 22 °C using the sparse-matrix screening solutions from 
Hampton Research and Emerald Biosystems. Drops contain 1.5 μL of the protein sample and 1.0 
μL of the well solution.  Screening yielded crystals after five days in a 20% Polyethylene glycol 
(PEG) 8000, 0.1 M phosphate-citrate buffer pH 4.5, 0.2 M NaCl condition. The crystals were 
approximately 10 μm thick needles that grow in clusters (Figure 4.1). Attempts to change the 
precipitant and pH to increase crystal quality were unsuccessful. Crystals were tested at  APS 
NE-CAT 24-ID-C beamline and diffracted to approximately 10 Å. 
Figure 4.1. HcyS/HcyD complex needle cluster crystals 
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Crystallization of the HcyS-GG/FSR complex 
 Frozen protein samples were thawed at 24 °C and the samples were mixed in a 1 FSR: 2 
HcyS-GG molar ratio and concentrated to 13.0 mg/ml. Crystallization was carried out by 
hanging-drop vapor-diffusion method at 22 °C using the sparse-matrix screening solutions from 
Hampton Research and Emerald Biosystems. Drops contain 1.5 μL of protein and 1.0 μL of the 
well solution. Screening yielded crystals after one day in a 1.2 M K2HPO4, 0.8 M NaH2PO4, 0.1 
M acetate pH 4.5 condition. The crystals were approximately 20 μm thick needles that grow in 
clusters (Figure 4.2). Optimization of the condition to lower K2HPO4 concentration of 0.9 M 
produced single crystals of a thickness of approximately 30 μm. Crystals were tested at the 
Advance Photon Source NE-CAT 24-ID-C beamline and did not diffract.  
 
Figure 4.2. FSR/HcyS-GG complex needle cluster crystals 
Production of HcyS-COAMP 
  The reaction mixture contained 2.5 mL of 2.0 mM HcyS-GG, 2.1 mL of 0.47 mM HcyF, 
150 µL of 50 mM ATP, and 30 µL of 1M MgCl2. The mixture was incubated for one hour at 
room temperature. The mixture was then loaded onto a Ni-column pre-equilibrated with buffer 
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A. The flowthrough was collected and bisulfide was added to the sample to a concentration of 2 
mM. The sample was then concentrated by centrifugation to an approximate concentration of 8.0 
mg/mL by Bradford assay [3]. The HcyF protein was eluted from the Ni-column with 10 mL of 
buffer B. Then concentrated by centrifugation to a concentration of 14 mg/mL by Bradford assay 
[28].  
Crystallization of the FSR/HcyS-COAMP complex 
 FSR and HcyS-COAMP frozen samples were thawed at 24 °C and mixed at a 1:1 molar 
ratio. Crystallization was carried out by hanging-drop vapor-diffusion method at 22 °C using the 
sparse-matrix screening solutions from Hampton Research and Emerald Biosystems. Drops 
contain 1.5 μL of protein and 1.0 μL of the well solution. Needle cluster crystals appeared after 
one day in a different condition from the FSR/HcyS-GG crystals (Figure 4.3). The new condition 
is 30% PEG 400, 0.1 M 3-(Cyclohexylamino)-1-propanesulfonic acid (CAPS) pH 10.5.   
Figure 4.3. HcyS-COAMP/FSR complex crystals  
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Section 4.3. Results  
Purification of the HcyS/HcyD complex 
The size exclusion chromatography trace of the mix of HcyS and HcyD is shown in Figure 4.4. It 
can be seen that there are two peaks the calculated approximate molecular weights of each of 
these peaks is shown next to the peaks. HcyS and HcyD have a molecular weight of 7.5 kDa and 
14.5 kDa respectively. SDS-PAGE analysis shows the peak 2 contains only HcyS. The SDS-
PAGE results show that samples of peak 1 contain both HcyD and HcyS (Figure 4.5). 
 
 
Figure 4.4. The size exclusion chromatography trace of the mix of HcyS and HcyD.  
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Figure 4.5. SDS-PAGE analysis of the size exclusion chromatography peaks shown in 
Figure 4.4 
 
Purification of the HcyF/HcyS complex 
 
 The size exclusion chromatography trace of the mixture of HcyS and HcyF is shown in 
Figure 4.6. This trace also has two peaks and the calculated approximate molecular weight of 
each peak is shown next to each peak. HcyF has an approximate molecular weight of 30 kDa, 
and HcyS has a molecular weight of 7.5 kDa. The approximate molecular weight of peak 2 is 
approximately 14 kDa and is shown through SDS-PAGE results to contain only HcyS. Peak 1 
has an approximate molecular weight of 60 kDa and SDS-PAGE analysis of the sample shows 
that it contains only HcyF (Figure 4.7) 
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Figure 4.6. Size exclusion chromatography trace of the mix of HcyS and HcyF  
 
Figure 4.7. SDS-PAGE analysis of HcyF and HcyS peaks shown Figure 4.6. 
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Purification of the FSR/HcyS complex 
 The size exclusion chromatography trace of the mix of FSR and HcyS is shown in Figure 
4.8. This trace has two peaks and the calculated approximate molecular weight of each peak is 
shown next to each peak. FSR has an approximate molecular weight of 86 kDa, and HcyS has a 
molecular weight of 7.5 kDa. The approximate molecular weight of peak 2 is approximately 14 
kDa and is shown through SDS-PAGE to contain only HcyS. Peak 1 has an approximate 
molecular weight of 170 kDa and contains only FSR by SDS-PAGE analysis (Figure 4.9).  
 
Figure 4.8. Size exclusion chromatography trace of the mix of HcyS and FSR. 
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Figure 4.9. SDS-PAGE analysis of FSR and HcyS peaks shown Figure 4.8. 
 
Section 4.4. Discussion 
 
 The approximate molecular weight of peak 2 (Figure 4.4, 4.6, and 4.8) for all of the size 
exclusion chromatography traces suggest that HcyS forms a dimer in solution. This is unusual 
when compared to the other sulfur carrier proteins. However, the size exclusion chromatography 
trace is not precise for such low molecular weights, so the dimer formation cannot be confirmed. 
In the HcyS/HcyD mix peak 1 could suggest that HcyD forms a dimer or that HcyD as a 
monomer forms a complex with the dimer of HcyS (Figure 4.4). SDS-PAGE analysis revealed 
that peak 2 contains HcyS and HcyD supporting the second possibility (Figure 4.5). These results 
show that HcyD and HcyS form a stable complex, which allowed crystallization. The overall 
oligomeric state of this complex cannot be determined from these results as the molecular weight 
is only estimated.  
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 Peak 1 of Figure 4.6 with an estimated molecular weight of 60 kDa could suggest a dimer 
of HcyF (30 kDa) or some complicated oligomeric state of HcyS and HcyF complex formation. 
However, the SDS-PAGE analysis shows the peak 1 contains only HcyF suggesting HcyF dimer 
formation (Figure 4.7).  The formation of a dimer is expected due to the structures of other 
activating enzymes of this type, which form a dimer. This includes ThiF and MoeB discussed in 
Chapter 2 [5,6]. This experiment was repeated with the HcyF and HcyS-GG, which is the state of 
the sulfur carrier protein that would form this complex (results not shown). The loss of the HcyS 
C-terminal alanine residue did not seem to have any effect on the results and there was still no 
evidence of complex formation. This suggests that HcyS and HcyF complex formation is not 
stable and is perhaps transient or that the ligands of the reaction ATP and Mg are needed to make 
the complex stable.   
 The FSR and HcyS mix peak 1 has an approximate molecular weight of 170 kDa, which 
is the same as the molecular weight of the FSR dimer seen at pH 8 and discussed in Chapter 5 
(Figure 4.8). Because of the large difference in molecular weight between the FSR and HcyS 
dimers it can be difficult to detect complex formation by molecular weight. However, SDS-
PAGE analysis of the peaks shown in Figure 4.9 shows that peak 1 contains only FSR showing 
no complex formation. If FSR and HcyS do form a complex it is likely not stable. The HcyS-GG 
and FSR mix was analyzed (results not shown), and the results were the same as shown in Figure 
4.8 and Figure 4.9. The HcyS-COAMP is the state of the sulfur carrier protein that would 
possibly interact with FSR. This mixture was not examined with size exclusion chromatography 
analysis because of the instability of the adenylated HcyS. It is still unknown whether HcyS and 
FSR form a complex or if another sulfur transfer protein accepts the sulfur from FSR and then 
transfers it to the HcyS C-terminal. 
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CHAPTER 5: STRUCTURAL STUDIES OF FERREDOXIN SULFITE REDUCTASE 
Section 5.1. Introduction 
Compounds containing sulfur are distributed throughout a variety of natural products 
including amino acids, carbohydrates, nucleic acids, cofactors [1]. The synthesis of these 
compounds draws from one of three sulfur sources in bacteria: free sulfide (cysteine 
biosynthesis), protein persulfides (iron sulfur cluster biosynthesis), and protein thiocarboxylates 
[2]. Protein thiocarboxylates or sulfur carrier proteins are part of a family of sulfide donors that 
are involved in a variety of biosynthetic pathways. This family includes ThiS (vitamin B1) [3], 
CysO (cysteine) [4], and MoaD (molybdopterin) [5]. Sulfur carrier proteins are generally of low 
molecular weight less than 10,000 Da with a Gly-Gly C-terminal motif and an ubiquitin-like 
fold. In some cases the Gly-Gly must be revealed by cleaving one or more amino acids present 
after the Gly-Gly motif.   
A search for ThiS orthologs uncovered a new sulfur carrier protein gene in Wolinella 
succinogenes, which is a Gram-positive bacterium and a member of the Heliobacteraceae group 
of ε-protobacterium. This group of bacterium contains several pathogens of humans and animals 
including Heliobacter pylori and Campylobacter jejuni [6]. Bioinformatics analysis of this W. 
succinogenes putative sulfur carrier protein gene showed that it was clustered with genes for 
methionine biosynthesis and sulfur assimilation. In this gene cluster, ferredoxin sulfite reductase 
(FSR) is responsible for the reduction of sulfite to sulfide, which is then transferred to the sulfur 
carrier protein in the thiocarboxylate-dependent methionine biosynthesis pathway (Figure 5.1). 
Other proteins identified in this pathway are a sulfur carrier protein (HcyS), a metalloprotease 
(HcyD), an adenylating enzyme (HcyF), and several proteins for methionine biosynthesis. The 
pathway begins when HcyS with a C-terminal alanine residue (HcyS-Ala) is cleaved by the 
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protease HcyD to reveal the C-terminal Gly-Gly motif (HcyS-GlyGly) that is characteristic of 
thiocarboxylate-dependent sulfur carrier proteins. HcyS-GlyGly is then adenylated by HcyF to 
yield HcyS-COAMP. The sulfite 10 is reduced to sulfide and then transferred by FSR to HcyS to 
replace the AMP making the thiocarboxylate HcyS-COSH [7]. Then OAH 11 is added to HcyS-
COSH through a condensation reaction is catalyzed by MetY to form 12 [7, 8]. An S,N-acyl shift 
occurs to form HcyS-homocysteine 13.  The homocysteine 3 is then cleaved from HcyS by 
HcyD. Finally, methylation of homocysteine 3 by MetE using 5-methyltetrahydrofolate as a 
cofactor finishes the methionine 4 biosynthesis [7].  
Figure 5.1. Thiocarboxylate-dependent methionine biosynthesis pathway  
The enzyme that provides the sulfur source for this pathway, FSR, is a sulfite reductase. 
Several structures of these sulfite or the very similar nitrite reductases have been solved and the 
mechanism of this reduction has been characterized [9]. This characterization is due to the 
necessity of the reduction of sulfite and nitrite to sulfide and ammonia respectively for the 
biological utilization of sulfur and nitrogen. Sulfite reductases (SiRs) and nitrite reductases 
(NiRs) use a novel prosthetic group assembly to perform a six-electron reduction. The active site 
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centers contain a reduced prophyrin of the isobacteriochlorin class called a siroheme that is 
covalently linked by a cysteine residue to a Fe4S4 cluster. This forms an electronically integrated 
metallo-cofactor for delivering electrons to the substrate. SiRs and NiRs are grouped into two 
classes assimilatory and dissimilatory. Assimilatory sulfite reductases (aSiRs) are found in 
bacteria, fungi, and plants, but not in animals and generate sulfide for incorporation into sulfur-
contains amino acids and cofactors. Dissimilatory sulfite reductases (dSiRs) are found primarily 
in diverse sulfate-reducing eubacteria, and thermophilic archaebacteria. The bacteria couples the 
reduction of sulfite with the terminal redox of the electron transport chain. The dSiRs can be 
distinguished from aSiRs by the tendency to produce incompletely reduced sulfur in the forms of 
trithionate (S3O62-) and thiosulfate (S2O32-) [10].  
 The structures of sulfite reductases have been solved from several organisms, including 
Escherichia coli (1AOP) [11], Spinacia oleracea (2AKJ) [12], Nicotiana tabacum (3B0L) [13], 
and Mycobacterium tuberculosis (1ZJ8) [14]. In E. coli SiR is part of a large protein complex 
including two parts referred to as the flavoprotein subunit and the hemoprotein subunit. The 
holoenzyme is made up of eight 66 kDa flavoprotein subunits, which accept electrons from 
NADPH and four 64 kDa hemoprotein subunits which accept electrons from the flavoprotein 
subunit and catalyzes the reduction of sulfite. However, the hemoprotein subunit is capable of 
reducing sulfite to sulfide, nitrite to ammonia, and hydroxylamine to ammonia without the 
flavoprotein being present as long as an electron source is provided [11]. Other SiRs are 
structurally similar to this hemoprotein subunit, with an r.m.s.d. of approximately 2.0 Å with 
three domains folding around the prosthetic groups in the center (Figure 5.2). Biologically, many 
of these SiRs use the protein ferredoxin as a source of electrons. Like the E.coli hemoprotein the 
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ferredoxin SiRs can catalyze the sulfite reduction without ferredoxin if another electron source is 
provided [14]. 
Figure 5.2. Sequence alignment of FSR with the assimilatory sulfite reductases which 
have structure deposited in the PDB database [11, 12, 13, 14] 
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The mechanism of the reduction has been well studied in the E.coli hemoprotein, but due to a 
high level of structural similarity to the ferredoxin SiRs, the same mechanism is associated with 
both. The overall reaction is a six electron transfer and is shown in Figure 5.3 and the mechanism 
is shown in Figure 5.4.  
7H+SO32- 6e- HS- 3H2O  
Figure 5.3. Overall reaction of the sulfite reduction to sulfide 
  The Fe4S4 cluster is in an oxidized overall 2+ state to start, the iron of the siroheme is 
also oxidized at an Fe (III) state 22 (Figure 5.4). The mechanism starts with a transfer of two 
electrons to the Fe4S4 cluster, one of which is transferred through the cysteine that covalently 
links the cluster to the siroheme iron. This changes the state of the cluster to 1+ and the siroheme 
iron to Fe (II) 23 (Figure 5.4). After this reduction of the cofactors, the substrate, sulfite, binds to 
the Fe (II) of the siroheme 24 (Figue 5.4). The basic residues above the siroheme stabilize the 
binding of the sulfite by forming hydrogen bonds with the oxygen atoms of the substrate. The 
electrons held by the Fe4S4 cluster and the siroheme iron are transferred to the sulfite, which 
destabilizes one of the oxygen sulfur bonds leading it to break 25 (Figure 5.4). Protons from the 
basic residues are donated to make H2O from the released oxygen, and the cofactors are returned 
to the cluster 2+ and siroheme Fe(III) states. This process is repeated twice as four electrons are 
transferred through the cofactor to the sulfite, the other two oxygens are released and form two 
H2O molecules 26 and 27 (Figure 5.4). The sulfide is then released from the cofactors, leaving 
them in the original [Fe4S4]2+ and Fe (III) state 22 (Figure 5.4) [9].  
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Figure 5.4. Mechanism of sulfite reductase, the Fe4S4 represents the iron sulfur cluster 
and the Fe III is the iron of the siroheme. The sulfur that is the covalent link between the 
two is from a protein cysteine residue.  
 
 The sulfite reductase of the thiocarboxylate-dependent methionine biosynthesis pathway, 
FSR has 764 residues making it larger than other sulfite reductases, which have approximately 
550 residues. The longer sequence of FSR suggests that it might be a fused multiple domain 
protein (Figure 5.5). The last 90 residues of FSR have sequence similarity to a sulfurtransferase, 
TusA [15]. 
 
Figure 5.5. FSR sequence diagram divided into domains identified by sequence 
alignments 
 
TusA is the first protein of a sulfur relay pathway that involves the transfer of sulfur to 
the wobble uridine of several tRNAs (Figure 5.6). The first position of the anticodon or the 
wobble position participates in the identification of the genetic code mediated by the codon-
anitcodon interaction. The uridine of the wobble position can receive a thio modification to make 
5-methylaminomethyl-2-thiouridine (mnm5s2U), which is important for specific recognition by 
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glutaminyl-tRNA synthetase [15]. A cysteine sulfur 5 is transferred to an IscS active site cysteine 
to make a persulfide through a PLP dependent reaction. TusA accepts the sulfur of IscS 
persulfide at its own active site cysteine residue [16]. The sulfide is then transferred to a cysteine 
residue of TusD, which is part of a complex with TusB and TusC. This transfer from the TusA 
persulfide to the TusD cysteine is stimulated by the interaction of TusE with the TusBCD 
complex. Then TusE accepts the sulfide from TusD at a cysteine residue forming a persulfide, 
which is then transferred to the protein MnmA and finally to tRNA to form the mnm5s2U 26 
[15].  
 
Figure 5.6. The sulfur transfer pathway to the tRNA, mnm5s2U that includes the 
sulfurtransferase TusA 
 
In addition to this function, studies have also suggested that TusA might be involved in 
the distribution of sulfur by the enzyme cysteine desulfurase IsCS. A part of this distribution is to 
the sulfur transfer pathway of the molybdenum cofactor (Moco) biosynthesis [17]. The 
biosynthesis of Moco is the final step of the molybdopterin (MPT) biosynthesis pathway 
discussed in Chapter 2, and involves the transfer of sulfur by a sulfur carrier protein (MoaD) 
[18]. MoaD is very similar to HcyS, the sulfur carrier protein of the methionine biosynthesis 
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pathway of which FSR is a part.  They have a sequence identity of 38 %, and both have the Gly-
Gly motif that forms the thiocarboxylate for sulfur transfer [7, 18]. According to TusA knockout 
studies, without TusA, IscS favors sulfur transfer to enzymes of iron-sulfur cluster biosynthesis. 
In these knockouts Moco biosynthesis is still accomplished but at a decreased efficiency. It 
seems that without TusA the rhodanese-like sulfur transferase YnjE preferentially accepts the 
sulfur from IscS and then transfers it to MoaD/MoaE complex that is called MPT synthase [17]. 
It had been shown in earlier studies that YnjE is capable of the transfer of sulfur to MPT 
synthase [19]. However, it is shown by the decrease of the Moco biosynthesis efficiency in the 
TusA knockout that TusA is somehow involved in the sulfur transfer to MPT synthase. It is 
currently unknown if it acts as YnjE accepting the sulfur from IscS and directly transferring it to 
MPT synthase, or if it transfers it to another sulfurtransferase to then transfer to MPT synthase 
[17].   
In this study we report a 2.4 Å resolution structure of FSR, the first documented structure 
of a sulfite reductase that is fused to a domain that has the same fold as HEPN domains and a 
disordered sulfur transferase domain. It transfers the sulfide to form a thiocarboxylate of a sulfur 
carrier protein. Comparing this structure to other proteins, we found that FSR residues 1-560 has 
the same fold of other sulfite/nitrite reductases, residues 580-670 has the same fold as HEPN 
domains. The structural similarities seen in this study and the published biochemical data 
supports the hypothesis that FSR reduces sulfite to sulfide and participates in the transfer of the 
sulfide to the sulfur carrier protein HcyS.     
Section 5.2. Materials and Methods 
Cloning and Overexpression of Selenomethioninyl (SeMet) FSR 
FSR and FSR N-terminal domain were cloned into a pET-28-based vector (Novagen) 
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with an N-terminal six histidine tag using standard molecular biology techniques [20, 21]. The 
FSR vector, Salmonella typhimurium cysG (siroheme synthase) vector, and Azotobacter 
vinelandii IscS cluster vector were coexpressed in Escherichia coli B834 (DE3) cells. An 
overnight culture was grown by the transfer of a colony to 30 mL of LB media supplemented 
with 30 µL of 40 mg/mL kanamycin, 30 µL of 100 mg/mL ampicillin, and 30 µL of 40 mg/mL  
chloramphenicol at 37 °C. The overnight cultures were pelleted at 4 °C by centrifugation for 10 
minutes at 4000g. The resulting cell pellet was resuspended in 10 mL of M9 minimal salts. The 
10 mL resuspended pellet was used to inoculate M9 minimal media (1L) supplemented with 10 
mL 40% glucose, 2 mL of 1M MgSO4, 1 mL of 0.1 M CaCl2, 10 mL of MEM vitamin solution, 
50 mg L-selenomethionine (SeMet), 100 mg of ampicillin, and 40 mg each of kanamycin and 
chloramphenicol. The 1 L cultures were grown at 37 °C to an OD600 of 0.4. Then 2.5 g of 
arabinose, 58.7 g of ferrous ammonium sulfate, and 90 mg of L-cysteine were added and the 
cultures was cooled to 15 °C while continuing to shake at 180 rpm. When the OD600 reached 0.6, 
30 mg of aminolevulinic acid and IPTG to a final concentration of 1 mM were added and 
shaking continued at 15 °C for 12-16 hours. Native FSR cells were grown in the same way 
except with media supplemented with 80 mg of DL-methionine instead of L-selenomethionine. 
Cells were pelleted by centrifugation at 4 °C for 30 minutes at 3300g. Cell pellets were stored at 
-20 °C until purification.  
Purification  
Cells were resuspended in 30 mL of buffer A [20 mM Tris pH 8.0, 333 mM  NaCl, 10 
mM Imidazole, and 1 mM DTT]. Cells were lysed by sonication, and cell lysate was separated 
by centrifugation at 4 °C for 45 minutes at 48000g. FSR was purified from the cell lysate by 
nickel affinity chromatography. The clarified lysate was incubated with 3 mL of nickel resin for 
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one hour; the mixture was then filtered through a column. The nickel resin was then washed with 
20 column volumes of buffer A. The protein was eluted with 3 column volumes of buffer A 
supplemented with 250 mM imidazole. The eluted protein was further purified by size-exclusion 
chromatography on an ÄKTAexplorer FPLC with a HiLoad 26/60 Superdex prep-grade G200 
column with buffer B [20 mM Tris (pH 8), 50 mM NaCl, 1 mM DTT]. The protein purity was 
determined by SDS-PAGE after the chromatography step. The SeMet protein was then 
concentrated to 20 mg/ml as determined by Bradford assay [22] using centrifugal concentrator 
and aliquots were flash-frozen and stored at -80 °C. The native FSR was concentrated to 14 
mg/ml as determined by a Bradford assay [22]. 
Crystallization SeMet full-length FSR  
 Frozen protein was thawed at 24 °C, and crystallization of SeMet FSR was carried out by 
hanging-drop vapor-diffusion method at 22 °C using sparse-matrix screening solutions from 
Hampton Research and Emerald BioSystems. Drops contained 1.5 μL of protein solution and 1.0 
μL of well solution. Screenings yielded crystals that appeared after approximately one month in a 
20% PEG 8000, 0.1 M 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) pH 7.5 
condition. The addition of 0.2 M potassium chloride to the condition grew higher quality 
crystals.  
Crystallization of FSR N-terminal domain 
 Frozen protein was thawed at 24 °C and crystallization of FSR N-terminal domain was 
carried out by hanging-drop vapor-diffusion method at 22 °C using sparse-matrix screening 
solutions from Hampton Research and Emerald BioSystems. Drops contained 1.5 µL of protein 
solution and 1.0 µL of well solution. Screening yielded crystals in the same condition as SeMet 
FSR with the same crystal morphology after one day. However, a 35% 2-methyl-2,4-pentanediol 
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(MPD), 0.2 M Li2SO4, 0.1 M 2-(N-Morpholino)ethanesulfonic acid (MES) pH 6.0 condition 
yielded higher quality crystals.   
Crystallization FSR co-crystallized with sulfide 
Crystallization of native FSR was carried out by hanging-drop vapor-diffusion method at 
22 °C using sparse-matrix screening solution from Hampton Research and Emerald BioSystems. 
Sodium sulfide was added to the protein sample to a final concentration of 2 μM and let incubate 
for 15 minutes before setting up the screens. Screening yielded crystals that appeared after one 
day in a 1.2 M sodium phosphate monobasic, 0.8 M potassium phosphate dibasic, 0.2 M Li2SO4, 
and 0.1 M CAPS pH 10.5 condition.   
Data Collection 
The crystals were dipped into a solution consisting of 20% PEG 8000, 0.2 M potassium 
chloride, 0.1 M HEPES pH 7.5 and 20% glycerol were flash-frozen in liquid nitrogen. Data was 
collected on a single SeMet crystal at the NE-CAT beamline 24-ID-C at the Advanced Photon 
Source (Argonne National Laboratory, Argonne, IL) using a Quantum 315 detector. To 
maximize the anomalous signal, a single-wavelength anomalous diffraction experiment was 
conducted at peak f for selenium. Two datasets were collected on this SeMet FSR crystal to 3.0 
Å resolution using a 1° oscillation range over 120 frames for each dataset. These two datasets 
were indexed, integrated, scaled and merged using the HKL2000 program suite [23]. Data-
collection statistics are shown in Table 5.1.  
FSR N-terminal domain crystals were not dipped in a cryogenic solution and were taken 
from the drop solution, 35% MPD, 0.2 M Li2SO4, 0.1 M MES pH 6.0. The data were collected at 
the Cornell High Energy Synchrotron Source (CHESS) A1 beamline. One data set was collected 
from this crystal to 2.4 Å using a 1° oscillation range for 180 frames. Data were indexed, 
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integrated, and scaled using the HKL2000 program suite [23]. Data-collection statistics are 
shown in Table 5.1.   
FSR sulfide co-crystallization crystals were dipped into a solution consisting of 0.8 M 
NaH2PO4, 0.8 M potassium K2HPO4, 0.2 M Li2SO4, 0.1 M CAPS pH 10.5, 10% glycerol, and 
10% ethylene glycol. Data was collected at the NE-CAT beamline 24-ID-C at the Advanced 
Photon Source. One data set was collected from this crystal to 2.4 Å using a 1° oscillation range 
over 120 frames. Data was indexed, integrated, and scaled using the HKL2000 program suite 
[23]. Data collection statistics are shown in Table 5.1. 
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Table 5.1. Summary of data collection statistics  
 SeMet FSR         
N-terminal 
Native FSR 
N-terminal 
FSR 2 mM 
Na2S 
Beamline APS NE-CAT  
24-ID-C 
CHESS A1 APS NE-CAT 
24-ID-C 
Wavelength (Å) 0.97918 0.97590 0.97910 
Space group P2
1
2
1
2
1
 P2
1
2
1
2
1
 P4
1
2
1
2
1
 
a (Å) 70.0 71.5 89.0 
b (Å) 127.4 127.1 89.0 
c (Å) 167.2 170.3 258.4 
Chains per asymmetric 
unit 
2 2 1 
Resolution (Å) 3.1 2.4 2.4 
Total number of 
reflections 
282631 322561 294868 
Number of unique 
reflectionsa 
57259(5726)b 60702(2913)b 41932(2060)b
Redundancy 9.2 (8.8)b 6.0 (5.7)b 7.0 (6.9)b
R
sym
c
(%) 10.8 (71.1)
b 7.0 (45.2)b 6.7 (47.6)b
I/ 21.9 (2.6)b 30.6(4.1)b 21.2 (3.3)b
Completeness (%)  99.4(99.4)b 98.4 (96.1)b 99.8 (100.0)b
 aUnique reflections include Bijvoet pairs. bValues in parentheses refer to the highest 
resolution shell. Rsym = ΣΣi|Ii − (I)|/Σ(I), where ሺIሻ is the mean intensity of N reflections 
with intensities Ii and common indices h, k, l. 
 
Structure Determination 
FSR contains 13 selenomethionine residues and the crystallographic asymmetric unit 
contains two monomers for a total of 26 selenomethionine residues. A total of 12 Se positions 
were located using hkl2map. Initial electron density maps were calculated using SAD phasing 
 
 
65 
 
and the position of the Se atom. A model was placed in the SeMet electron density map using 
MOLREP [24]  real space molecular replacement using Spinacia oleracea nitrite reductase 
structure (PDB entry 2AKJ) as model [12]. CHAINSAW [25] was used to remove atoms that 
were not common to the two sequences. The FSR N-terminal domain data were used to extend 
the resolution of this structure to 2.4 Å resolution. The siroheme, Fe4S4 cluster, and 254 waters 
were added to the structure during refinement. Refinement was performed using 
PHENIX.REFINE [26] and alternated with successive manual model building using COOT [27] 
guided by Fo - Fc and 2Fo - Fc maps. The geometry of FSR was validated using PROCHECK 
[28]. Refinement statistics are shown in Table 3.2. 
The FSR/sulfide complex structure was determined using molecular replacement as 
implemented in the program PHENIX.PHASER [26] with the SeMet FSR structure as the search 
model. The model corresponding to residues 570-673 was built with PHENIX.AUTOBUILD 
[26]. Refinement was performed using PHENIX.REFINE [26] and alternated with manual model 
building using COOT [27], and 306 water molecules were added to the structure. The geometry 
of FSR was validated using PROCHECK [28]. Refinement statistics are shown in Table 5.2. 
Figure Production  
All figures were made with PyMol [29], ESCript 2.2, and Accelrys Draw [Accelrys]. 
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Table 5.2 Summary of data refinement statistics 
 FSR N-terminal 
Residues (1-560) 
FSR 
Residues (4-673) 
Resolution (Å) 2.4 2.4 
No. of protein atoms 8600 5036 
No of ligand atoms 193 96 
No. of water atoms 254 308 
Reflections in the working set 59150 41859 
Reflections in the test set 3007 1543 
R factora (%)  18.5 15.4 
Rfree (%)  24.1 19.2 
R.m.s.d from ideals   
Bond lengths (Å) 0.013 0.010 
Angles (Å) 1.52 1.42 
Average Bfactor (Å3) 37.4 36.37 
Favored (%) 97.4 97.3 
Allowed (%) 2.6 2.7 
Disallowed (%) 0.0 0.0 
aR factor = ∑hkl||Fobs| − k|Fcal||/∑hkl|Fobs|, where Fobs and Fcal are observed and 
calculated structure factors, respectively. bRfree, the sum is extended over a subset of 
reflections (5%) excluded from all stages of refinement. 
 
Section 5.3. Results 
The Matthews coefficient [30] for the FSR N-terminal crystals was calculated to be 2.17 Å3/Da, 
assuming two monomers in the asymmetric unit, which corresponds to a solvent content of 43%. 
The final model included two monomers and had an Rfactor and Rfree of 18.5% and 24.1%, 
respectively. Each monomer contains residues 7-560 of 764 possible amino acid residues. The C-
terminal region, residues 561-764, has no electron density. The crystals were analyzed by SDS-
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PAGE and the molecular weight was seen to be approximately 60 kDa (the full length FSR 
protein is 86 kDa), which suggests that the electron density of the C-terminal region is missing 
due to proteolysis. Proteolysis is further supported by crystallization of the FSR N-terminal 
domain protein, which only contains residues (1-560), in the same condition, space group, and 
approximate unit cell parameters. Each monomer in the asymmetric unit contains one active site, 
each of which contains a Fe4S4 cluster and a siroheme. This N-terminal region of FSR is 
structurally similar to other sulfite and nitrite reductases and contains three domains. According 
to size exclusion chromatography results at a pH of 8.0, FSR N-terminal is a monomer in 
solution.  
 The Matthews coefficient [30] for the FSR/sulfide complex crystals was calculated to be 
2.98 Å3 Da-1, which assuming one monomer in the asymmetric unit corresponds to a solvent 
content of 58.79%. The final model included one monomer and had an Rfactor and Rfree of 15.5% 
and 19.5% respectively. Of 764 possible amino acid residues, the structure contains residues 4-
673. The C-terminal region residues 674-764 are disordered and the electon density is missing. 
This monomer contains the same three domains as the FSR N-terminal domain structure and one 
extra domain. 
Structure of FSR 
FSR likely contains five structural domains.  The first three domains are visible in the SeMet 
FSR structure, and the first four domains are visible in the FSR/sulfide complex.  Domain 1 
contains two β-sheets: the first contains five antiparallel β-strands flanked by five α-helices, and 
the second contains four antiparallel β-strands flanked by two α-helices. Domain 2 contains a 
four stranded mostly parallel β-sheet (β5↓β6↓β7↑β8↓) surrounded by four solvent exposed α-
helices. Domain 3 has a four-stranded mostly parallel β-sheet (β14↓β15↓β16↑β17↓) flanked by 
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seven solvent exposed α-helices. Domain 4 contains five α-helices (Figure 5.7). Residues 632-
764 likely form domain 5, the domains is missing because of proteolysis in the SeMet FSR 
structure, and disordered in the FSR/sulfide complex (Figure 5.8). 
 
Figure 5.7. Stereodiagram of each of the four domains with α-helices colored in blue, β-
strands colored in green, and loops colored in yellow.   
 
 
69 
 
 
Figure 5.8. (A) Topology diagram of FSR /sulfide complex structure with α-helices 
shown in blue and β-strands shown in green. Colored boxes represents the secondary 
structure that belongs to each domain: Domain 1 (blue), Domain 2 (green), Domain 3 
(red), Domain 4 (yellow). (B) Monomer of FSR structure with α-helices labeled and 
shown in blue and β-strands labeled and shown in green. (C) Monomer of FSR structure 
domains colored to correspond to the colored boxes of the topology diagram. Linker 
regions between domains are colored in purple.  
(A) 
(B) (C) 
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FSR Dimer 
 Size exclusion chromatography at pH 8.0 suggests that the full-length FSR is a dimer in 
solution. Although the N-terminal FSR structure contains two molecules in the asymmetric unit 
the two molecules do not form a dimer, which agrees with the N-terminal monomer size 
exclusion chromatography results. The FSR/sulfide complex structure has one molecule in the 
asymmetric unit and no dimer is present in the crystallographic symmetry. This FSR structure is 
a monomer which disagrees with the size exclusion chromatography results for full-length FSR. 
However, when the size exclusion chromatography experiment was repeated at the same pH of 
the crystallization condition (phosphate buffer of pH 6.2), the estimation of the molecular weight 
suggests that FSR is a monomer at this pH. 
Siroheme group 
 The siroheme prosthetic group (tetrahydroporphyrin of the isobacteriochlorin class) that 
consists of a metalloporphyrin that contains an Fe (III) bound in the center of the ring (Figure 
5.8). The Fe (III) is responsible for the electron transfer in the sulfite reduction reaction, and is 
coordinated to the sulfur of the Cys446, which links it to the Fe4S4 cluster. In the FSR structure, 
the Fe (III) of the siroheme is bound to sulfate, which is in the sulfite binding site. The distal face 
of the siroheme is surrounded by several basic residues Arg164, Lys167, Arg124, Arg55, Arg88, 
and Lys 165. These form hydrogen bonds with the siroheme to stabilize its binding to FSR 
(Figure 5.9)  
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Figure 5.9. Stereodiagram of the siroheme cofactor 
Fe4S4 cluster 
 The Fe4S4 cluster of sulfite reductases start in an overall (2+) state. The Fe4S4 cluster has 
four iron atoms that are coordinated to the four sulfur atoms of the cluster and the four sulfur 
atoms of four cysteine residues. Cys396, Cys404, Cys442, and Cys446 in the FSR structures 
(Figure 5.10).     
 
 
 
Figure 5.10. Stereodiagram of the iron sulfur cluster from FSR structure coordinated with 
the cysteines (Cys398, Cys404, Cys442, Cys446) 
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Figure 5.11. Stereodiagram of FSR active site. Residues labeled and colored by domain. 
Domain 3 is red  
 
Sulfate binding site 
 
Both the N-terminal and FSR/sulfide complex structure have a negatively charged ion, sulfate, 
bound in active site. The sulfate forms hydrogen bonds with the residue Arg55, Arg124, Lys165, 
and Lys 167 (Figure 5.11). In the FSR/sulfide complex structure, above the distal face of the 
siroheme, Cys570 extends into the active site from a linker between domains 3 and 4 (Figure 
5.12). The sulfur of Cys570 is 3.9 Å from the sulfur atom of the bound sulfate. This residue’s 
position suggests that the Cys570 would accept the product of the sulfite reduction sulfide for 
sulfur transfer to the sulfur carrier protein HcyS. Despite being necessary for the crystallization 
condition, sulfide is not seen in the structure. 
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Figure 5.12. FSR structure residues (4-673) colored by domains: domain 1(blue), domain 
2 (green), domain 3 (red), domain 4 (yellow). Linker region shown in purple. The linker 
between domain 3 and 4 that overlays the active site and inserts a cysteine into the active 
site is labeled.  
 
 Section 5.4. Discussion  
Comparison of FSR and homologs 
 A DALI search of the FSR N-terminal structure and the sulfide co-crystallization 
structure identified several structural homologs [31]. The top hit for the sulfide co-crystallization 
is an assimilatory sulfite reductase (aSir) from Mycobacterium tuberculosis (PDB code 1ZJ9) 
[14] with a Z score of 36.3 and an aligned sequence identity of 25%. All the top hits are nitrite or 
sulfite reductases and have approximately 540 residues and three α/β domains (Table 5.3). 
Domain 1 forms hydrogen bonds with the siroheme and provides basic residues for the sulfite 
binding site. Additionally, domain 1 has two parts separated in the sequence by domain 2. 
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Domain 2 forms the other half of the siroheme and sulfite binding site interactions. Then domain 
3 interacts with the Fe4S4 cluster. When the FSR N-terminal structure is superimposed with the 
three domains of the sulfite reductase (1ZJ9), the r.m.s.d. is 1.6 Å (Figure 5.13).  No other 
assimilatory sulfite or nitrite reductase structure currently in the PDB database is fused with 
other domain types like is seen in the FSR/sulfide complex structure.   
The active sites of these sulfite and nitrite reductase homologs are similar to FSR. The 
top hits all include a Fe4S4 cluster coordinated to four cysteine residues with one cysteine 
forming a bridge between the Fe4S4 cluster and the iron atom of the siroheme. The distal face of 
the siroheme is surrounded by basic residue to provide protons for the reduction and to stabilize 
the binding of the negatively charged sulfite ion. Also these basic residues form hydrogen bonds 
with the siroheme to stabilize the binding of the prosthetic group. However, none of these 
structures have a cysteine residue to accept the sulfide for transfer as FSR Cys570.   
Table 5.3 Summary of top results of the FSR N-terminal DALI search 
PDB code Protein Z-score R.m.s.d Sequence 
identity (%) 
1zj9 Sulfite reductase 
(Mycobacterium tuberculosis) 
36.3 2.3 25 
2akj Nitrite reductase  
(Spinacia oleracea) 
35.5 2.3 26 
2gep Sulfite reductase  
(Escherichia coli) 
32.0 2.7 19 
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Figure 5.13. FSR N-terminal structure (red) overlaid with sulfite reductase (PDB code 
1zj9) (blue) [14]. Structures have the same fold and the r.m.s.d is 1.6 Å. 
 
Oligomeric structure and domain organization in comparison to homologs  
 
These other sulfite reductases are all monomers, which makes the dimer formation at pH 
8.0 suggested by the size exclusion chromatography results more unusual. However, since FSR 
is a monomer at the pH of the crystallization condition, the functional differences created by the 
dimer formation cannot be predicted.  
A DALI search of the FSR domain four (residues 570-674) yielded structural homologs 
[32]. The top hit is a hypothetical protein (NP_069135.1; PDB code 2HSB) [results not yet 
published] with a Z score 8.6 and a sequence alignment of 9% (Figure 5.14).  
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Figure 5.14. FSR domain four structure (red) overlaid with the 2HSB (HEPN domain) 
structure (blue) [34]. The r.m.s.d is 2.1 Å and shows that domain four has the same fold 
as the HEPN domain.  
 
This structure, as well as the other top hits of the DALI search, is identified as a HEPN 
(higher eukaryotic and prokaryotic nucleotide binding) domain (Table 5.4). The function of this 
type of domain is not completely known, however it is suggested that it will bind monophosphate 
nucleotide molecules [34]. This implies that this domain in FSR would be involved in binding of 
the AMP molecule of the adenylated HcyS.  
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Table 5.4. Summary of top DALI search results for FSR domain four  
PDB code Protein Z-score R.m.s.d. Sequence 
identity (%) 
2hsb HEPN domain (Archaeoglobus fulgidus) 8.6 2.1 9 
3o10 Sacsin HEPN domain (Homo sapien) 7.2 2.6 6 
1o3u HEPN domain (Thermatoga maritima) 6.9 2.5 10 
1kny Kanamycin Nucleotidyltransferase 
(Staphylococcus aureus) 
6.0 6.8 11 
 
FSR domain four was superimposed with the kanamycin nucleotidyltransferase (KNTase) 
(PDB code 1KNY) [35], which contains an HEPN domain and a nucleotidyltransferase 
domain and the structure contains the nucleotide diphosphomethylphosphonic acid adenosyl 
ester (AMPCPP). Comparison of the KNTase nuceleotide binding site to FSR shows some 
conservation of the residues involved in the binding (Figure 5.15). These conserved 
interactions are made up by a dimer of the HEPN domain in KNTase [33]. Two of the four 
AMPCPP binding interactions of the HEPN domain are conserved in FSR domain 4. This 
HEPN dimer might be recreated in the FSR dimer (at biological pH) and bind the AMP of 
adenylated HcyS. However, because the sequence identity is very low between the FSR 
domain four and KNTase, and only part of the interactions are conserved, it is possible that 
domain four only has the same fold as the HEPN domain. It might be that domain four does 
not function in the binding of the adenylated HcyS, and is only present to anchor the linker 
between domains three and four and allow Cys570 to be inserted into the active site.     
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Figure 5.15. FSR domain 4 (pink) superimposed with the 1KNY structure (blue). The 
1KNY is a dimer with a HEPN domain in each monomer. Two copies of the FSR domain 
4 is overlaid with each of the HEPN domains. The AMPCPP is bound between the HEPN 
domains of the dimer with interactions from both chains. The 1KNY Ser18 form a 
hydrogen bond with the adenine ring, In FSR there is Asp619 close to the same position 
the side chain is pointed up in this structure but a different rotamer could allow it to form 
the same hydrogen bond. The second interaction is 1KNY Glu145 which form a 
hydrogen bond with the oxygen of the first phosphate of AMPCPP. The FSR Glu587 is in 
the same position and could form the same interaction. The other two interaction of 
1KNY are Lys149 and Asn152 with phosphate two and three, which do not overlay with 
any similar residues in FSR. In FSR the α-helix is shorter and forms a loop at this 
position with Gly591, Gly592, Asp593, and a Glu594, which are not in position to 
interact with AMPCPP. This could be because the FSR would bind AMP where 1KNY 
binds ATP [33].  
 
FSR Disordered Domain 
 The disordered region (residues 674-764) in the FSR/sulfide complex structure 
shows 50% identity with a putative sulfurtransferase TusA from Candidatus Nitrospira 
defluvii (YP_003798379), and a 27% identity with a TusA ortholog from E. coli from which 
the structure has been solved (PDB code 1DCJ) [34]. Biochemical studies of TusA show that 
Cys19TusA accepts a sulfide from IscS and forms a persulfide. The sulfide is then transferred 
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from TusA to another protein TusD and eventually to tRNA to make the mnm5s2U 
modification. Genomic analysis of bacterial sulfurtransferases has identified large proteins 
that contain TusA sulfurtransferases, different from rhodanese homology domains, at their C-
terminal in Episilion (W. succinogenes) and Delta proteobacteria and Clostridia [35]. A 
multiple sequence alignment (Figure 5.16) of FSR C terminal region, 1DCJ (TusA), and 
other sulfurtransferases of this type identifies Cys703FSR as important for sulfide transfer. 
Because of the disorder of the region containing Cys703, further study is needed to establish 
the role of Cys703 and the C-terminal putative sulfertransferase region. 
 
Figure 5.16. Multiple sequence alignment for FSR disordered domain (680-764). The Sir 
protein is another approximately 760 residue putative sulfite reductase fused with other 
domains that has not been characterized, TusA and SirA proteins are small (about 100 
residues) sulfurtransferases. The conserved cysteine at FSR position 23 is Cys703 in the 
complete protein sequence. This conserved cysteine in TusA E.coli is the active site 
cysteine that forms the persulfide 
 
 
Mechanism of FSR 
The Fe4S4 cluster is in an oxidized overall 2+ state to start, the iron of the siroheme is 
also oxidized at an Fe (III) state 22 (Figure 5.17). The mechanism starts with a transfer of two 
electrons to the Fe4S4 cluster, one of which is transferred through the cysteine that covalently 
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links the cluster to the siroheme iron. This makes the state of the cluster to 1+ and the siroheme 
iron Fe (II) 23. After the reduction of the cofactors the substrate, sulfite, binds to the Fe (II) of 
the siroheme 24. The basic residues above the siroheme stabilize the binding of the sulfite by 
forming hydrogen bonds with the oxygen atoms of the substrate. The electrons held by the Fe4S4 
cluster and the siroheme iron are transferred to the sulfite, which destabilizes one of the oxygen 
sulfur bonds leading it to break 25. Protons from the basic residues are donated to make H2O 
from the released oxygen, and the cofactors are returned to the cluster 2+ and siroheme Fe(III) 
states. This process is repeated twice as four electrons are transferred through the cofactor to the 
sulfite, the other two oxygen bonds are broken and form two H2O molecules 26 and 27. The 
sulfide is then released from the cofactors, leaving them in the original [Fe4S4]2+ and Fe (III) 
state 22 [9]. Based on the cysteine in the active site, the sulfide would then form a persulfide 
with Cys 570. The sulfide is then transferred to the sulfur carrier protein HcyS to form the C-
terminal thiocarboxylate, whether this involves another intermediate persulfide transfer is 
currently unclear.  
 
 
 
Figure 5.17. Mechanism of FSR, the Fe4S4 represents the iron sulfur cluster and the Fe III 
is the iron of the siroheme. The sulfur that is the covalent link between the two is from a 
protein cysteine residue Cys446.  
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Section 5.5. Conclusions 
 Unlike previously characterized sulfite reductases, which have approximately 560 
residues and contain three structural domains, W. succinogenes FSR contains 
approximately 760 residues with five structural dontains.  The first three structural 
domains are homologous to those of conventional sulfite reductases.  Domains 4 and 5 
were missing in the first FSR structure as the result of proteolysis.  A new condition 
containing sulfide resulted in a crystal structure in which domain 4 was ordered, but 
domain 5 was not, even though no proteolysis had occurred.  Surprisingly, domain 4, 
which showed no sequence similarity to any structure in the PDB, is structurally 
homologous to HEPN nucleotide binding domains, suggesting that domain 4 might bind 
adenylated HcyS for sulfur transfer and thiocarboxylate formation.  In addition, Cys570 
in the linker between domains 3 and 4 was found in the FSR active site about 4 Å from 
the predicted sulfite sulfur atom position, suggesting the possibility of a sulfur transfer 
mechanism involving Cys570 persulfide formation.  Interestingly, domain 5 is 
homologous to TusA, which has been shown to aid sulfur transfer in other sulfur carrier 
protein pathways through cysteine (equivalent to Cys703 in HcyS) persulfide formation.  
Whether Cys570 transfers the sulfide directly to HcyS, or transfers the sulfide to Cys703 
in domain 5, which then subsequently transfers it to the HcyS is currently unknown.  
Mutagenesis and kinetic studies are currently underway to unravel this question. 
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CHAPTER 6: CONCLUSION 
 Using X-ray crystallography to examine structure has provided insight into protein 
function and mechanism for decades. The act of growing crystals, collecting diffraction patterns, 
and determining a protein structure at an atomic resolution has altered our understanding of 
molecular machinery of cellular pathways. In a protein structure knowing the position of every 
atom can provide key catalytic residues that provide insight into a proteins function and 
mechanism.  
 For example, the structure of ferredoxin sulfite reductase (FSR) reported in Chapter 5 
provides new information about the transfer of sulfur in pathways of sulfur carrier proteins. 
Sulfur carrier protein pathways have been significantly studied over that last few years and 
despite the extensive study of the pathways including thiamin [1], cysteine [2], and 
molybdopterin [3] the new variation in sulfur transfer methods are still being discovered. Many 
of the thiocarboxylates of the sulfur transfer proteins are made through the transfer of a sulfur 
from a persulfide created by a cysteine desulferase, like IscS [4]. However, sometimes there is 
another protein containing a rhodanese-like domain that accepts the persulfide to transfer it to the 
sulfur carrier protein [5]. There is also evidence another type of sulfurtransferase TusA could 
also transfer the sulfur to make the thiocarboxylate [6]. In the sulfur carrier protein dependent 
methionine biosynthesis the sulfur source is unusually supplied by FSR. The sulfide would then 
react with the C-terminal of  the activated sulfur carrier protein HcyS in a nucleophilic attack [7]. 
FSR was thought to only be involved in the reduction of sulfite providing an excess amount of 
sulfide. However, the structure of FSR provided insight into a more complex function. The 
structure demonstrates that it is a multiple domain protein that seems to be a fusion of several 
smaller proteins with different functions.  
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 The crystal structure of FSR residues (4-673) presented in Chapter 5 was determined to a 
resolution of 2.4 Å, using molecular replacement from the FSR N-terminal structure which 
solved by SAD phasing. It is similar to other sulfite reductases, except it contains another 
domain. This other domain (domain four) is separated from domain three by a long linker that 
overlays the active site. The presence of the Cys570 residue inserted into the active site from this 
linker suggests that FSR is involved in the formation of a persulfide for eventual sulfur transfer 
to the HcyS thiocarboxylate. The last 90 residues of FSR structure are disordered, but the region 
has significant sequence identity with the sulfurtransferase TusA further suggesting the function 
of FSR to be involved in the transfer of the sulfide after the reduction. This is the only structure 
of a sulfite reductase currently solved with a cysteine positioned to accept the sulfide for sulfur 
transfer.  
 The sulfur carrier protein HcyS of this same pathway is also of interest for the structural 
elements it uses to form complexes. Since HcyS must complex with several other proteins the 
structural properties that allow this variety of protein-protein interactions are very interesting. 
The studies of HcyS complex formation are presented in Chapter 4. The only complex that is 
stable enough to observe through size exclusion chromatography is the HcyS/HcyD complex, 
which is the first step of the methionine biosynthesis pathway. The other complex formation 
HcyS/HcyF and HcyS/FSR might be sensitive to state of ligand binding and the state of the HcyS 
C-terminal, which is the catalytic region of the protein and is modified by each protein in the 
pathway. It is possible that complex formation is highly sensitive to the state of these 
modifications as only the HcyS/HcyD complex, the first step of the pathway requiring no 
modification, is stably formed. The attempts to tests the HcyS-GG ability to form a stable 
complex with HcyF did not show any change in complex formation. This might be due to the 
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need for the ligands for the reaction ATP and Mg2+ for stable complex formation. Overall, the 
complex formation seems to be rather unstable due to changes in HcyS C-terminal and ligand 
binding.  
 The sulfur carrier protein dependent methionine biosynthesis pathway provides new 
opportunities to probe structural elements and functions of interesting enzymes. A collaboration 
of structural biologists and mechanistic enzymologists will continue to work to elucidate these 
structural questions.                      
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